In a meeting http://realeconomylab.org/erekton-olimp-forum.pdf#bricks erekton ultra  The panel voted 14-2 to approve the drug for cutaneous leishmaniasis, the most common form. It voted 15-1 in favor for visceral leishmaniasis, the most severe form; and it voted 13-3 in favor for mucosal disease.